Clinical Trial Update: Propofol vs Sevoflurane in Cyanotic Congenital Heart Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing propofol to sevoflurane in pediatric patients with cyanotic congenital heart disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cyanotic Congenital Heart Disease
• Heart Disease

Drugs mentioned

• PROPOFOL (Propofol)
• Sevoflurane (Sevoflurane)

Snippet

Sponsor: Cukurova University | Conditions: Cyanotic Congenital Heart Disease, Pediatric HD | Phase 4 | Status: COMPLETED